英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

doubler    
n. 倍压器,倍频器;并线机;倍增器

倍压器,倍频器;并线机;倍增器

doubler
二倍器

doubler
倍器

doubler
n 1: an electronic device that doubles the voltage or the
frequency of an input signal


请选择你想看的字典辞典：
单词字典翻译
Doubler查看　Doubler　在百度字典中的解释百度英翻中〔查看〕
Doubler查看　Doubler　在Google字典中的解释Google英翻中〔查看〕
Doubler查看　Doubler　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • General Clinical Practice Use of Nadofaragene Firadenovec . . .
    Practical Considerations for Nadofaragene Firadenovec Use e firadenovec, including administration, monitoring, supportive care, and patient education Successful instillation of nadofaragene fir denovec requires understanding its transportation, storage, and administration requirements While urolo-gy clinics and ealth car Figure 1
  • Package Insert and Information for Patients - Adstiladrin
    11 DESCRIPTION ADSTILADRIN (nadofaragene firadenovec-vncg) is a non-replicating adenoviral vector-based gene therapy for intravesical instillation
  • Nadofaragene Firadenovec-vncg Monograph for Professionals . . .
    After the instillation, allow nadofaragene firadenovec-vncg to be left in the bladder for 1 hour During the 1 hour dwell time, the patient should reposition approximately every 15 minutes See Full Prescribing information for additional instructions on preparation and administration of nadofaragene firadenovec-vncg
  • ADSTILADRIN | FDA - U. S. Food and Drug Administration
    STN: BLA 125700 Proper Name: nadofaragene firadenovec-vncg Tradename: ADSTILADRIN Manufacturer: Ferring Pharmaceuticals A S Indication: High-grade, Bacillus Calmette-Guerin (BCG) unresponsive non
  • Nadofaragene firadenovec-vncg (urinary bladder route)
    Description Nadofaragene Firadenovec-vncg is used to treat patients with high-risk Bacillus Calmette-Guerin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) with a tumor type called carcinoma in situ (CIS) with or without papillary tumors This medicine is to be used only by or under the direct supervision of a doctor
  • ADSTILADRIN® (nadofaragene firadenovec-vncg) | For HCP
    Nadofaragene firadenovec- vncg (ADSTILADRIN) is A recommended treatment option: In the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)* and the AUA SUO Guidelines1 By the International Bladder Cancer Group (IBCG) for high-risk NMIBC after BCG failure for those seeking to avoid radical cystectomy 2
  • Adstiladrin: Package Insert Prescribing Information MOA
    ADSTILADRIN (nadofaragene firadenovec-vncg) is a non-replicating adenoviral vector-based gene therapy for intravesical instillation It is a recombinant adenovirus serotype 5 vector containing a transgene encoding the human interferon alfa-2b (IFNα2b)
  • IP02-36 Use of Rectal Diazepam to Prevent Bladder Spasms and . . .
    Erratum IP02-36 Use of Rectal Diazepam to Prevent Bladder Spasms and Leakage of Medication During Intravesical Administration of Nadofaragene Firadenovec in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Erratum
  • HCP Resources | ADSTILADRIN® (nadofaragene firadenovec-vncg)
    DOSAGE AND ADMINISTRATION: Administer ADSTILADRIN by intravesical instillation only ADSTILADRIN is not for intravenous use, topical use, or oral administration USE IN SPECIFIC POPULATIONS: Advise females of reproductive potential to use effective contraception during ADSTILADRIN treatment and for 6 months after the last dose
  • Package Insert - ADSTILADRIN
    11 DESCRIPTION ADSTILADRIN (nadofaragene firadenovec-vncg) is a non-replicating adenoviral vector-based gene therapy for intravesical instillation It is a recombinant adenovirus serotype 5 vector containing a transgene encoding the human interferon alfa-2b (IFNα2b) ADSTILADRIN has a nominal concentration of 3 x 1011 vp mL





中文字典-英文字典  2005-2009